$NKSH

National Bankshares, Inc. Reports Results for the Three and Six Months Ended June 30, 2026

NATIONAL BANKSHARES INC (NKSH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nksh-ex99_1.htm NATIONAL BANKSHARES, INC. PRESS RELEASE, DATED MARCH 24, 2025 EX-99.1 EXHIBIT 99.1 FOR IMMEDIATE RELEASE CONTACTS: Lara Ramsey, President and CEO Lora M. Jones, Treasurer & CFO (540) 951-6250 lramsey@nbbank.com (540) 951-6238 ljones@nbbank.com National B

Original reporting
Published Jul 23, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NKSH
Bullish
medium confidence
Mentioned
$NKSH
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NKSHBullishMed
01

Why it matters

Traders can update expectations for NKSH’s 2026-2027 net interest margin and interest income based on the quantified securities repositioning, while also adjusting for the end of Bearing Insurance-related annual bonus commission.

02

Market read

NKSH provides quantified NIM and interest income uplift expectations from securities repositioning, alongside a one-time equity sale gain and the discontinuation of an insurance bonus commission.

03

What to watch

The repositioning includes a pre-tax loss of $6.55M expected to be recovered over 1.8 years, and the deposit mix includes meaningful uninsured non-municipal deposits, which could matter if funding conditions tighten.

Relevance 7/10Novelty 7/10Timing: after-hours filing of 8-K with Q2 results and portfolio repositioning details

Background

This is an SEC 8-K (Item 2.02) with a press release covering National Bankshares’ results through June 30, 2026, plus commentary on portfolio actions and liquidity/credit posture.

Company-level read

Ticker impact

$NKSHBullishMedium confidence
Context

National Bankshares reports Q2 and six-month results, including a $6.57M gain from selling its Bearing Insurance stake and a securities portfolio repositioning.

Expected impact

Near-term upside bias versus prior-year comparables, but follow-through depends on whether the projected net interest margin uplift materializes after the one-time Bearing Insurance commission ends.

Evidence & confidence

The filing provides concrete datapoints: net income up sharply year over year, a specific $6.57M gain on sale, and quantified NIM/interest income expectations from the securities repositioning. However, it also notes the insurance-related annual bonus commission will not recur, which can cap sustained momentum.

Market effects

Small-cap bank earnings disclosures highlight how securities portfolio yield management and deposit cost trends drive net interest margin.

Limited to the company’s Virginia market footprint, with potential read-across for other community banks on deposit pricing and liquidity posture.

Low; no direct global macro or cross-border catalyst beyond general rate sensitivity.

Counterpoint

The headline improvement is partly driven by a one-time $6.57M gain and a non-recurring insurance commission, so core earnings power may be less strong than the year-over-year jump suggests.

Key entities

  • National Bankshares, Inc.

    Parent company of The National Bank of Blacksburg and National Bankshares Financial Services, Inc., reporting Q2 and six-month 2026 results.

  • Bearing Insurance Group, LLC

    NKSH sold its membership interest in Q2 2026, recording a $6.57M gain.

  • Federal Home Loan Bank of Atlanta (FHLB)

    NKSH cites borrowing lines with FHLB as part of its liquidity position.

Related articles

$ANGOMed

AngioDynamics Q1 Earnings Call Highlights

AngioDynamics (ANGO) reported Q1 revenue growth in NanoKnife, up 29% to $8.3M, with probe sales rising 24.1% and capital sales up 53.5%. The company expects AlphaReturn to expand its product line. Gross margin improved to 59.4%, and adjusted EBITDA increased to $5M. The company reaffirmed its fiscal 2027 outlook, expecting revenue of $336M-$341M and adjusted EBITDA of $13M-$16M.

$LEVIMed

Levi Strauss (LEVI) Q3 2026 Earnings Call Transcript

Levi Strauss (LEVI) reported Q3 2026 earnings, with revenue up 5% organically. International business grew 8%, led by Asia. Global Wholesale rose 6%, and non-denim categories contributed 50% of top-line growth. DTC performance lagged due to softer traffic in the U.S. and Europe, but improvements are expected in Q4. The company appointed John Vandemore as its next CFO, replacing Harmit.

$APLDMed

Applied Digital (APLD) Q1 2027 Earnings Call Transcript

Applied Digital (APLD) reported $36B in contracted revenue across 5 campuses. The company plans to add 600MW capacity in the next 12 months, up from 250MW. APLD focuses on long-term AI factory designs and targets 15-year contracts with Tier 1 hyperscalers. They secured a 1,200MW power agreement in North Dakota, strengthening their expansion plans.

$RGPMed

RGP (RGP) Q1 2027 Earnings Call Transcript

RGP reported Q1 2027 revenue of $98.1M, gross margin of 37.4%, and adjusted SG&A expense of $40.3M. Revenue was impacted by lower project volume in the Consulting segment and cautious client decision-making. The company is addressing these issues with urgency and accountability, while seeing long-term demand indicators. They are also simplifying operations and aligning cost structure with revenue.